Literature DB >> 28956103

Pediatric lymphangiography, thoracic duct embolization and thoracic duct disruption: a single-institution experience in 11 children with chylothorax.

Bill S Majdalany1, Wael A Saad2, Jeffrey Forris Beecham Chick2, Minhaj S Khaja2, Kyle J Cooper2, Ravi N Srinivasa2.   

Abstract

BACKGROUND: Interventional radiology treatment of chylothorax is well described in adults, with high technical and clinical success that decreases patient morbidity and mortality. However there is limited experience in children.
OBJECTIVE: To report the technical and clinical success of lymphangiography, thoracic duct embolization and thoracic duct disruption in the pediatric population.
MATERIALS AND METHODS: We studied 11 pediatric patients (7 boys, 4 girls; median weight 6.0 kg) who underwent lymphangiography and thoracic duct embolization from November 2015 to May 2017. All 11 (100%) children presented with chylothorax, with 1 (9%) having concomitant chylous ascites and 1 (9%) having concomitant chylopericardium. Ten (91%) children had traumatic chylothorax and one (9%) had congenital chylothorax. We recorded technical success, clinical success and complications.
RESULTS: Twelve procedures were completed in 11 children. Bilateral intranodal lymphangiography was technically successful in all (100%) patients. Central lymphatics were visualized in eight (67%) procedures. Access to central lymphatics was attempted in eight procedures and successful in five (63%). In three (37%) of the eight procedures, disruption was performed when the central lymphatics could not be accessed. Clinical success was achieved in 7/11 (64%) children. Three minor complications were reported. No major complications were encountered.
CONCLUSION: Lymphangiography, thoracic duct embolization and thoracic duct disruption are successful interventional strategies in children with chylothorax and should be considered as viable treatment options at any age.

Entities:  

Keywords:  Children; Chylothorax; Embolization; Interventional radiology; Lymphangiography; Thoracic duct

Mesh:

Year:  2017        PMID: 28956103     DOI: 10.1007/s00247-017-3988-5

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  23 in total

1.  LYMPHANGIOGRAPHY IN CHILDREN.

Authors:  M H GOUGH
Journal:  Arch Dis Child       Date:  1964-04       Impact factor: 3.791

2.  Retrograde Thoracic Duct Embolization in a Pediatric Patient with Total Cavopulmonary Connection and Plastic Bronchitis.

Authors:  Alex Chung; Anne E Gill; Feraz N Rahman; C Matthew Hawkins
Journal:  J Vasc Interv Radiol       Date:  2015-11       Impact factor: 3.464

3.  Percutaneous embolization of a chylous leak from thoracic duct injury in a child.

Authors:  Aisling L Snow; Wibke Uller; Hueng Bae Kim; Ahmad I Alomari
Journal:  Cardiovasc Intervent Radiol       Date:  2014-01-03       Impact factor: 2.740

Review 4.  ACR Appropriateness Criteria® Chylothorax Treatment Planning.

Authors:  Bill S Majdalany; Douglas A Murrey; Baljendra S Kapoor; Thomas R Cain; Suvranu Ganguli; Michael S Kent; Fabien Maldonado; Joseph J McBride; Jeet Minocha; Stephen P Reis; Jonathan M Lorenz; Sanjeeva P Kalva
Journal:  J Am Coll Radiol       Date:  2017-05       Impact factor: 5.532

5.  Feasibility of ultrasound-guided intranodal lymphangiogram for thoracic duct embolization.

Authors:  Gregory J Nadolski; Maxim Itkin
Journal:  J Vasc Interv Radiol       Date:  2012-03-21       Impact factor: 3.464

6.  Percutaneous thoracic duct embolization as a treatment for intrathoracic chyle leaks in infants.

Authors:  Maxim Itkin; Ganesh Krishnamurthy; Maryam Y Naim; Geoffrey L Bird; Marc S Keller
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

7.  Intranodal lymphangiography: feasibility and preliminary experience in children.

Authors:  Mohammad Reza Rajebi; Gulraiz Chaudry; Horacio M Padua; Brian Dillon; Sabri Yilmaz; Ryan W Arnold; Mary F Landrigan-Ossar; Ahmad I Alomari
Journal:  J Vasc Interv Radiol       Date:  2011-06-29       Impact factor: 3.464

8.  Postoperative chylothorax after cardiothoracic surgery in children.

Authors:  Emily H Chan; Jennifer L Russell; William G Williams; Glen S Van Arsdell; John G Coles; Brian W McCrindle
Journal:  Ann Thorac Surg       Date:  2005-11       Impact factor: 4.330

9.  Medical and surgical management of chylothorax and associated outcomes.

Authors:  Fabien Maldonado; Rodrigo Cartin-Ceba; Finn J Hawkins; Jay H Ryu
Journal:  Am J Med Sci       Date:  2010-04       Impact factor: 2.378

10.  Successful treatment of plastic bronchitis by selective lymphatic embolization in a Fontan patient.

Authors:  Yoav Dori; Marc S Keller; Jack Rychik; Maxim Itkin
Journal:  Pediatrics       Date:  2014-07-07       Impact factor: 7.124

View more
  6 in total

Review 1.  Complications during Lymphangiography and Lymphatic Interventions.

Authors:  Bill S Majdalany; Mamadou L Sanogo; Waleska M Pabon-Ramos; Kyle A Wilson; Abhishek K Goswami; Nima Kokabi; Minhaj S Khaja
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

2.  Lymphatics, Long a Mystery-Primed to Make History.

Authors:  Bill S Majdalany
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

Review 3.  Contemporary lymphatic interventions for post-operative lymphatic leaks.

Authors:  Bill S Majdalany; Ghassan El-Haddad
Journal:  Transl Androl Urol       Date:  2020-01

Review 4.  Traumatic Chylothorax: Approach and Outcomes.

Authors:  Shenise N Gilyard; Minhaj S Khaja; Abhishek K Goswami; Nima Kokabi; Wael E Saad; Bill S Majdalany
Journal:  Semin Intervent Radiol       Date:  2020-07-31       Impact factor: 1.513

5.  Novel use of a Synovis™ coupler device for a surgical lymphovenous anastomosis for the treatment of refractory chylothorax in a patient with central lymphatic flow disorder.

Authors:  Joshua Rezkalla; Majid Husain; Ginger Slack; Sanjay Sinha
Journal:  Clin Case Rep       Date:  2022-03-20

6.  A breathless teenager.

Authors:  Cara N Cochrane; Neil Collin; Simon C Langton Hewer
Journal:  Breathe (Sheff)       Date:  2021-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.